Frempong, T. and Pearson, H.A. (2007) Newborn Screening Coupled with Comprehensive Follow-Up Reduced Early Mortality of Sickle Cell Disease in Connecticut. Connecticut Medicine, 71, 9-12.

has been cited by the following article:

• TITLE: Study of Sickle Cell Anemia with Clinical and Hematological Correlation (Provincial Hospital EL Idrissi, Morocco)

  AUTHORS: Asmaa Belala, Alkhali Arwa, Ikram Mark, Sadek Sanae, Dakir Zahra, Mouden Samira, Driss Belghyti, Khadija El Kharrim

  KEYWORDS: Sickle Cell Anemia, Thalassemia-Haematological Parameters, Kenitra-Morrocco

  JOURNAL NAME: Open Journal of Epidemiology, Vol.7 No.2, May 31, 2017

  ABSTRACT: Sickle cell anemia is an autosomal recessive genetic disease by mutation of the β globin gene. This mutation induces the synthesis of abnormal hemoglobin (Hb) HbS, Mainly responsible for all clinical manifestations vaso-occlusives and chronic hemolysis with variable anemia. The objective of this study is the determination profile of haematological parameters of sickle cell children of the province of Kenitra (Morocco). In order to know the usual values and the particularities which are its own, we have observed that 50% of sickle cell children in our case study have severe anemia and 84% in patients aged 5 to 11 years. In addition, there is no significant difference among gender. The cases of hemoglobinosis S are divided into: Homozygous hemoglobinosis S (43%), Heterozygous sickle cell disease (17%), Hemoglobinosis S associated with alpha-thalassemia (1%), Hemoglobinosis S composite heterozygosity S/beta-thalassemia (5%), S/PHHF composite heterozygosity (6%), eventually composite heterozygosity S/beta+ thalassemia (28%). Homozygous sickle cell children have a long hospital stay, the highest number of hospitalizations and very severe sickle cell syndromes compared to the other phenotypic status of our population.